| Bioactivity | SLU-PP-1072 is a dual ERRα/γ inverse agonist, used in Prostate cancer (PCa) research. SLU-PP-1072 disrupts PCa cell metabolism, and induces apoptosis via dysregulating cell cycle[1]. | ||||||||||||
| Name | SLU-PP-1072 | ||||||||||||
| CAS | 2285432-57-5 | ||||||||||||
| Formula | C18H12N2O3S | ||||||||||||
| Molar Mass | 336.36 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Schoepke E, et al. A Selective ERRα/γ Inverse Agonist, SLU-PP-1072, Inhibits the Warburg Effect and Induces Apoptosis in Prostate Cancer Cells. ACS Chem Biol. 2020 Sep 18;15(9):2338-2345. |
SLU-PP-1072
CAS: 2285432-57-5 F: C18H12N2O3S W: 336.36
SLU-PP-1072 is a dual ERRα/γ inverse agonist, used in Prostate cancer (PCa) research. SLU-PP-1072 disrupts PCa cell me
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.